Hetlioz (Vanda Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Hetlioz drug offered from Vanda Pharmaceuticals Inc.. This Melatonin Receptor Agonist [EPC],Melatonin Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Vanda Pharmaceuticals Inc.
NON-PROPRIETARY NAME: tasimelteon
SUBSTANCE NAME: TASIMELTEON
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Melatonin Receptor Agonist [EPC],Melatonin Receptor Agonists [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-04-04
END MARKETING DATE: 0000-00-00


Hetlioz HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHetlioz from Vanda Pharmaceuticals Inc.
LABELER NAME: Vanda Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/1)
START MARKETING DATE: 2014-04-04
END MARKETING DATE: 0000-00-00
PRODUCT ID: 43068-220_9dfa71b8-de12-491a-82cd-7ebb8a6f2823
PRODUCT NDC: 43068-220
APPLICATION NUMBER: NDA205677

Other TASIMELTEON Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Vanda Pharmaceuticals Inc.Hetlioz